Genistein aglycone: a dual mode of action anti-osteoporotic soy isoflavone rebalancing bone turnover towards bone formation.
about
Dietary Management of Skin Health: The Role of Genistein.Effects of flaxseed lignan and oil on bone health of breast-tumor-bearing mice treated with or without tamoxifen.Differential effects of short term feeding of a soy protein isolate diet and estrogen treatment on bone in the pre-pubertal rat.Chemopreventive and chemotherapeutic effects of genistein, a soy isoflavone, upon cancer development and progression in preclinical animal modelsNovel daidzein analogs enhance osteogenic activity of bone marrow-derived mesenchymal stem cells and adipose-derived stromal/stem cells through estrogen receptor dependent and independent mechanismsAntiosteoporotic Activity of Genistein Aglycone in Postmenopausal Women: Evidence from a Post-Hoc Analysis of a Multicenter Randomized Controlled Trial.Functions and action mechanisms of flavonoids genistein and icariin in regulating bone remodeling.Pharmaceutical properties of calycosin, the major bioactive isoflavonoid in the dry root extract of Radix astragali.Dual Effects of Liquiritigenin on the Proliferation of Bone Cells: Promotion of Osteoblast Differentiation and Inhibition of Osteoclast Differentiation.Genistein inhibits osteoclastic differentiation of RAW 264.7 cells via regulation of ROS production and scavenging.Soybean isoflavone ameliorates β-amyloid 1-42-induced learning and memory deficit in rats by protecting synaptic structure and function.The Effects of Kaempferol-Inhibited Autophagy on Osteoclast Formation.Prevention of retinoic acid-induced osteoporosis in mice by isoflavone-enriched soy protein.Association of estrogen receptor β and estrogen-related receptor α gene polymorphisms with bone mineral density in postmenopausal women.
P2860
Q33852146-E54DBBFF-85F7-4BA9-B2F5-DA6E3AAFD872Q33889613-C01C32C4-9B1D-47E2-AA44-AD354C96DB73Q34247505-988A845F-6974-434F-8B29-5BB2DE2C311DQ35014332-EC0C1487-8BF5-464D-9EBB-098ABC25F028Q35164591-E1F232F8-CC68-4F40-B158-392BF67D2410Q37673312-2D9B993F-F2A0-4B9A-9D32-7F47F63ACB63Q38025048-6E3896F4-C835-48D1-A1AE-76EE5F512C02Q38196430-A369CD88-3E6B-46C3-9F0D-3964C1549504Q38853262-775FE278-76C7-4449-BA21-927F6116B0AEQ38985154-0DAE74A1-D3B4-4285-A7B4-4FBCD757D817Q43671966-AB42D08F-481C-44D6-8A57-5CB9BC747DBEQ48308535-4BF0AC99-7144-4026-8FCB-89706DC6C681Q53628139-CEFDA18F-8BA1-40E7-9761-FDBEBE53874DQ53802328-C8FAF2FC-4F81-45BE-AFBE-FA4DB2CEF77B
P2860
Genistein aglycone: a dual mode of action anti-osteoporotic soy isoflavone rebalancing bone turnover towards bone formation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Genistein aglycone: a dual mod ...... rnover towards bone formation.
@en
Genistein aglycone: a dual mod ...... rnover towards bone formation.
@nl
type
label
Genistein aglycone: a dual mod ...... rnover towards bone formation.
@en
Genistein aglycone: a dual mod ...... rnover towards bone formation.
@nl
prefLabel
Genistein aglycone: a dual mod ...... rnover towards bone formation.
@en
Genistein aglycone: a dual mod ...... rnover towards bone formation.
@nl
P2093
P1476
Genistein aglycone: a dual mod ...... urnover towards bone formation
@en
P2093
D Altavilla
F Squadrito
L Minutoli
P304
P356
10.2174/092986710791959738
P577
2010-01-01T00:00:00Z